Augmentation of Clozapine Due to Inadequate Treatment Response in Schizophrenia: Comparison of Patients with Augmented and Non-augmented Treatments

Senol S. H., Gurcan G., ERTUĞRUL A., KARAHAN S., ANIL YAĞCIOĞLU A. E.

TURK PSIKIYATRI DERGISI, vol.32, no.1, pp.1-7, 2021 (SSCI) identifier identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 32 Issue: 1
  • Publication Date: 2021
  • Doi Number: 10.5080/u25076
  • Journal Name: TURK PSIKIYATRI DERGISI
  • Journal Indexes: Social Sciences Citation Index (SSCI), Scopus, Central & Eastern European Academic Source (CEEAS), EMBASE, MEDLINE, Psycinfo, TR DİZİN (ULAKBİM)
  • Page Numbers: pp.1-7
  • Keywords: Schizophrenia, clozapine, augmentation, treatment resistant, TREATMENT-RESISTANT SCHIZOPHRENIA, OBSESSIVE-COMPULSIVE SCALE, 2ND-GENERATION ANTIPSYCHOTICS, REFRACTORY SCHIZOPHRENIA, METAANALYSIS, RELIABILITY, EFFICACY, TURKISH
  • Hacettepe University Affiliated: Yes

Abstract

Objective: Clozapine is considered to be a gold standard antipsychotic in treatment resistant schizophrenia. This study aims to investigate clozapine augmentation methods utilized in schizophrenia and compare the sociodemographic characteristics, clinical features and remission states of patients whose treatments are augmented and not.